Growth Hacking Strategies & Scaling

Chapter 6
Experimentation and Evidence-Based Decision Making

Post Graduate Program in Entrepreneurship
Growth Hacking Strategies & Scaling   •   Post Graduate Diploma

Experimentation and Evidence-Based Decision Making

Introduction

Growth hacking is often misunderstood as a collection of rapid marketing tricks. In a rigorous sense, it is a disciplined approach to discovering scalable mechanisms for acquiring, activating, retaining, monetising and referring customers. Its central capability is not speed alone, but the ability to generate reliable learning under conditions of uncertainty.

Entrepreneurial firms rarely possess complete information. Customer needs evolve, markets are noisy, competitors respond, and early samples are usually small. Consequently, managers must make decisions using imperfect evidence while avoiding the temptation to treat every movement in a metric as proof of causation. Experimentation provides a structured way to convert uncertainty into learning. Evidence-based decision making connects that learning to resource allocation, product design and scaling choices.

An experimentation system links five activities:

  1. identifying a decision or problem;
  2. formulating a falsifiable hypothesis;
  3. prioritising and designing an appropriate test;
  4. analysing evidence with statistical and causal reasoning; and
  5. documenting, communicating and applying the learning.

The objective is not to make every experiment successful. A well-designed experiment can produce a valuable negative result if it prevents the organisation from investing in an ineffective idea.

Learning Objectives

By the end of this chapter, the reader should be able to:

  • distinguish opinion, observation, hypothesis and evidence;
  • formulate testable growth hypotheses;
  • apply ICE and RICE prioritisation responsibly;
  • select suitable MVPs and experimental designs;
  • explain A/B testing, randomisation, control groups and statistical uncertainty;
  • distinguish correlation from causation and recognise threats to causal inference;
  • interpret conversion, uplift, confidence intervals and practical significance;
  • identify analytical biases and ethical risks; and
  • create a learning repository that supports cumulative organisational knowledge.

1. From Ideas to Testable Hypotheses

An idea is a proposed action: “We should add social login.” A hypothesis is a conditional, measurable claim about an outcome: “If first-time users are offered social login during registration, the completed-registration rate will increase because account creation requires less effort.”

A useful hypothesis specifies:

  • Target population: whom the intervention affects;
  • Intervention: what will change;
  • Mechanism: why the change is expected to work;
  • Outcome metric: what will be measured;
  • Expected direction and magnitude: how much change is anticipated; and
  • Time horizon: when the effect should appear.

A practical template is:

For [customer segment], changing [intervention] is expected to change [metric] from [baseline] to [target] within [period], because [mechanism].

The statement should be falsifiable. “Customers will like the new page” is vague; “Among new mobile visitors, the redesigned page will increase completed sign-ups by at least 10% over fourteen days” can be tested.

Metrics and metric hierarchy

A growth system should distinguish between a primary metric, secondary metrics, guardrail metrics and diagnostic metrics.

  • The primary metric represents the main decision criterion, such as activated users per visitor.
  • Secondary metrics provide supporting information, such as registration completion.
  • Guardrails detect harmful side effects, such as refunds, complaints, latency or unsubscribes.
  • Diagnostic metrics explain the mechanism, such as click-through rate or time spent in a workflow.

A metric should be defined operationally. For example:

Conversion rate = Number of users completing the target action ÷ Number of eligible users

The numerator and denominator must refer to the same population and time period. If “users” in the numerator are counted over a month but “visitors” in the denominator are counted by sessions, the result is difficult to interpret.

A useful entrepreneurial metric is often a rate, retention proportion, time-to-event, or unit-economic measure, rather than a vanity count. Ten thousand impressions may sound impressive, but contribution margin per acquired customer is more relevant to scaling.

2. Prioritising Experiments: ICE and RICE

A firm cannot test every idea. Prioritisation creates a transparent basis for deciding which experiments deserve scarce engineering, design and managerial attention.

ICE scoring

ICE evaluates Impact, Confidence and Ease. A common form is:

ICE score = (Impact × Confidence × Ease) ÷ 3

Each factor is normally rated on a consistent ordinal scale, such as 1 to 10. The arithmetic average is not a probability and should not be interpreted as one. It is a decision aid that makes assumptions visible.

  • Impact: expected importance if the hypothesis is correct.
  • Confidence: strength of existing evidence supporting the hypothesis.
  • Ease: relative feasibility, considering time, cost, technical complexity and risk.

For example, an experiment rated Impact = 8, Confidence = 6 and Ease = 7 has:

ICE score = (8 × 6 × 7) ÷ 3 = 112

The score has meaning only relative to the scores of other ideas evaluated using the same rubric.

RICE scoring

RICE adds estimated reach and is useful when experiments affect substantially different numbers of users:

RICE score = (Reach × Impact × Confidence) ÷ Effort

Reach is the estimated number of unique people affected during a stated period. Impact may use a defined scale, such as 0.25 for minimal, 0.5 for low, 1 for medium, 2 for high and 3 for massive. Confidence is expressed as a proportion between 0 and 1. Effort may represent person-weeks or another consistently defined resource measure.

Suppose an experiment has Reach = 4,000 users per month, Impact = 1, Confidence = 0.8 and Effort = 4 person-weeks:

RICE score = (4,000 × 1 × 0.8) ÷ 4 = 800

RICE is not a forecast of profit. It is a prioritisation index. High reach can make a weak idea appear attractive, while a low-reach experiment may be strategically important if it tests a foundational assumption.

Critical use of prioritisation scores

Scores should not override judgement. Teams should separately consider:

  • legal, privacy and safety risks;
  • dependencies and irreversible commitments;
  • learning value, especially for uncertain strategic assumptions;
  • whether the experiment can be implemented without contaminating other tests; and
  • whether a high score merely reflects optimistic estimates.

A lightweight review can ask: “What evidence would change this score?” This helps prevent numerical precision from disguising subjective assumptions.

3. MVPs as Learning Instruments

A minimum viable product (MVP) is the smallest credible intervention that allows a team to test a meaningful value or business assumption. It is not necessarily a low-quality version of the final product. Its appropriate form depends on the hypothesis.

Examples include:

  • a landing page measuring qualified interest;
  • a concierge service delivered manually before automation;
  • a prototype tested through observed tasks;
  • a limited geographic launch;
  • a pre-order or deposit test for willingness to pay; and
  • a “wizard-of-oz” interface in which the customer sees automation while humans perform the back-end work.

An MVP should minimise irrelevant construction while preserving the mechanism being tested. If the hypothesis concerns trust in automated financial advice, a mock-up with no credible explanation of data protection may test visual appeal rather than trust.

The strongest MVPs define a learning threshold before launch. For example: “Proceed to engineering investment if at least 15% of qualified visitors request a demonstration and fewer than 5% report a critical trust concern.” This prevents post hoc reinterpretation of ambiguous results.

MVPs also require ethical boundaries. A firm must not misrepresent a product, collect unnecessary personal information, create false scarcity or expose customers to unsafe service merely to obtain data.

4. Designing Controlled Experiments

A/B testing

In an A/B test, eligible units are randomly assigned to a control condition (A) or treatment condition (B). The control represents the current experience or a neutral comparison; the treatment contains the proposed change.

Randomisation is essential because it tends, on average, to balance both observed and unobserved characteristics between groups. Without it, treatment users may differ systematically from control users.

The basic workflow is:

  1. define the population and unit of randomisation;
  2. select the primary and guardrail metrics;
  3. specify the analysis window and stopping rule;
  4. implement assignment and exposure tracking;
  5. verify that users received the intended experience;
  6. analyse the pre-specified outcome; and
  7. decide whether to adopt, modify, reject or retest.

The unit may be a user, account, household, store, session or geographic region. It should match the possible interference pattern. If users influence one another through referrals, individual randomisation may violate the assumption that one person’s treatment does not affect another person’s outcome. Cluster or geo-randomisation may be more suitable.

Conversion difference and relative uplift

Let pA be the control conversion proportion and pB the treatment conversion proportion. The absolute treatment effect is:

∆ = pB − pA

The relative uplift, when pA > 0, is:

Relative uplift = (pB − pA) ÷ pA × 100%

If control conversion is 10% and treatment conversion is 12%, the absolute increase is 2 percentage points, while relative uplift is 20%. These are not interchangeable statements.

For a simple difference in proportions, an approximate standard error is:

SE(∆) = √[pA(1 − pA) ÷ nA + pB(1 − pB) ÷ nB]

where nA and nB are the numbers of observations in control and treatment. This approximation assumes independent observations and sufficiently large samples for the normal approximation to be reasonable. If assignment is clustered, observations are repeated, or counts are small, alternative methods are required.

An approximate 95% confidence interval for the difference is:

∆ ± 1.96 × SE(∆)

The interval estimates a range of effects compatible with the data under the model. It does not mean there is a 95% probability that the fixed effect lies inside this particular computed interval.

#### Worked example

A control group has 1,000 visitors and 100 conversions; a treatment group has 1,000 visitors and 120 conversions. Thus, pA = 0.10 and pB = 0.12.

∆ = 0.12 − 0.10 = 0.02

The standard error is approximately:

SE(∆) = √[(0.10 × 0.90 ÷ 1,000) + (0.12 × 0.88 ÷ 1,000)] ≈ 0.0140

Therefore, an approximate 95% interval is:

0.02 ± 1.96 × 0.0140 ≈ 0.02 ± 0.0274

or approximately −0.007 to 0.047. Since the interval includes zero, the data do not provide strong evidence of a non-zero difference at this conventional threshold. The observed uplift may still be commercially interesting, but more evidence or a better-powered design is needed.

Statistical significance and practical significance

Statistical significance asks whether the data are unusual under a specified null model. Practical significance asks whether the estimated effect is large enough to justify implementation costs, risks and opportunity costs. A tiny effect can be statistically significant with a very large sample; a strategically important effect can fail to reach a conventional threshold in a small sample.

Teams should report effect size, uncertainty, sample size, exposure quality and business implications—not only a p-value. A p-value is not the probability that the hypothesis is true, nor is it a measure of managerial value.

Sample size and power

Before an experiment, teams should consider:

  • baseline conversion or outcome variance;
  • minimum detectable effect (MDE);
  • desired power, commonly 80% or 90%;
  • significance level, often 5%;
  • allocation ratio; and
  • expected attrition or invalid exposure.

Power is the probability of detecting an effect of a specified size under assumed conditions. If the MDE is unrealistically small, the required sample may be commercially impractical. A pre-test power analysis is preferable to stopping when results become favourable.

Sequential monitoring, repeated peeking and stopping at the first attractive result can inflate false-positive risk unless a sequential testing method or an appropriate alpha-spending plan is used. Multiple variants and multiple metrics create additional multiplicity problems. A team should pre-specify a primary outcome and treat exploratory findings as hypotheses for further testing.

5. Causal Inference Beyond A/B Tests

The central causal question is: “What would have happened to the same unit at the same time if it had not received the intervention?” This unobserved alternative is the counterfactual. Randomised experiments estimate causal effects because random assignment makes treatment status independent of potential outcomes in expectation, subject to implementation quality and interference assumptions.

Observational data can reveal associations but may be confounded. For example, customers who use a premium feature may retain longer because the feature helps them—or because highly motivated customers are more likely to use it.

Threats to causal validity

  • Selection bias: exposure is related to characteristics that also affect outcomes.
  • Confounding: a third variable influences both treatment and outcome.
  • Survivorship bias: analysis includes only those who remain observable.
  • Attrition: dropout differs between groups.
  • Instrumentation changes: tracking or definitions change during the test.
  • Novelty and primacy effects: behaviour changes temporarily because an experience is new or because users initially react strongly.
  • Spillovers: treatment affects control units.
  • Regression to the mean: extreme observations naturally move closer to average on repeated measurement.

Quasi-experimental approaches

When randomisation is impossible, several designs can improve inference:

  • Before–after analysis: compares outcomes before and after intervention, but is vulnerable to concurrent trends.
  • Difference-in-differences: compares changes over time in a treated group with changes in a comparison group. Its key assumption is parallel trends: absent treatment, both groups would have followed similar trends.
  • Regression discontinuity: exploits a known assignment threshold; it estimates a local effect near the cutoff and requires no manipulation around that threshold.
  • Instrumental variables: use a variable that changes treatment exposure but affects the outcome only through treatment. Valid instruments are difficult to find.
  • Matched or weighted comparisons: balance measured covariates but cannot automatically remove unmeasured confounding.

These methods are valuable but do not transform weak data into certainty. Their assumptions must be stated and examined.

6. Evidence Quality and Analytical Biases

An evidence hierarchy is context-dependent, but a well-executed randomised experiment generally offers stronger causal evidence than a descriptive dashboard. However, an experiment with poor exposure tracking or severe attrition may be less credible than a carefully designed observational study.

Common biases include:

  • Confirmation bias: seeking evidence that supports an existing belief;
  • HARKing: presenting a post hoc explanation as if it were predicted in advance;
  • p-hacking: trying many analyses until one appears significant;
  • survivorship bias: ignoring failed products, churned users or abandoned experiments;
  • availability bias: overvaluing vivid anecdotes;
  • novelty bias: interpreting temporary excitement as durable value;
  • denominator neglect: reporting a large count without its base;
  • Goodhart’s law: when a measure becomes a target, it may cease to be a good measure; and
  • local optimisation: improving one funnel step while reducing long-term retention or profitability.

A disciplined team maintains an experiment registry containing the question, hypothesis, owner, population, intervention, primary metric, guardrails, analysis plan, launch date, result, decision and follow-up. Results should be recorded whether positive, negative or inconclusive. This prevents repeated tests of failed ideas and protects institutional memory when employees leave.

A learning document should distinguish:

  • Observed: what the data directly show;
  • Inferred: the explanation most consistent with the evidence; and
  • Decided: the action chosen, including its uncertainty and owner.

7. A Scalable Experimentation Operating System

A mature experimentation system requires more than software. It needs governance, technical reliability and managerial discipline.

Governance and roles

A compact experiment brief should identify:

ElementRequired question
DecisionWhat decision will the result inform?
HypothesisWhat change is expected and why?
PopulationWho is eligible, and what is the unit?
MetricsWhat is primary, secondary and a guardrail?
DesignHow are assignment and exposure controlled?
AnalysisWhat method and stopping rule will be used?
RiskWhat harms, privacy issues or dependencies exist?
Decision ruleWhat outcomes lead to adoption, revision or rejection?

Product, growth, data, engineering, legal and customer-support functions may all have legitimate interests. A single owner should be accountable for the experiment, while independent review is appropriate for high-risk interventions.

Data quality

Before trusting a result, verify:

  • randomisation balance or assignment integrity;
  • correct treatment exposure;
  • duplicate, bot and fraud handling;
  • consistent event definitions;
  • missing data and attrition;
  • time-zone and seasonality effects; and
  • whether other launches contaminated the test.

A statistically sophisticated analysis of incorrectly logged events remains invalid.

Scaling decisions

A positive local test is not automatically a scaling decision. The team should ask whether the effect:

  • persists beyond the test window;
  • generalises to other segments or channels;
  • survives increased volume;
  • remains profitable after operational costs;
  • creates customer or regulatory harm; and
  • interacts with other parts of the product or funnel.

A staged rollout—such as 5%, 25%, 50% and then 100%—can limit risk while monitoring guardrails. Rollback criteria should be defined before launch.

8. Ethics, Privacy and Responsible Use of AI

Experimentation changes people’s experiences, and therefore has ethical consequences. Informed consent requirements vary by jurisdiction and context, but transparency, proportionality and respect for autonomy are foundational principles. Firms should avoid experiments that exploit vulnerable populations, conceal material risks, discriminate against protected groups or make essential services inaccessible.

Personalisation and experimentation may involve behavioural data. Organisations should apply data minimisation, purpose limitation, access control, retention limits and appropriate anonymisation or pseudonymisation. Consent and lawful processing must be assessed in the relevant jurisdiction. Sensitive attributes should not be used as convenient optimisation variables without a compelling, lawful and ethically reviewed purpose.

AI can support experiment design by generating hypotheses, classifying qualitative feedback, detecting anomalies and estimating heterogeneous treatment effects. However, AI-generated recommendations may reproduce historical bias, leak confidential information or create false confidence. Human review, reproducibility, model documentation and subgroup fairness checks remain necessary. An algorithm should not be allowed to optimise a proxy that systematically harms a minority group merely because the aggregate metric improves.

9. Illustrative Case: LearnLoop’s Activation Experiment

Background

LearnLoop, a fictional subscription platform for professional courses, had strong visitor growth but weak activation. Only 18% of new registered users completed a first lesson within seven days. Interviews suggested that the catalogue was overwhelming, but the team did not know whether guided onboarding would solve the problem.

Problem and hypothesis

The team formulated this hypothesis: “For new registered users, a three-question goal selector followed by one recommended course will increase seven-day first-lesson completion by at least 15% relative to the existing catalogue, without increasing seven-day cancellations.”

The primary metric was first-lesson completion within seven days. The cancellation rate was a guardrail. Registration rate was monitored because the onboarding could introduce friction.

Analysis and approach

The team prioritised the experiment using ICE: Impact = 8, Confidence = 6 and Ease = 6, producing:

ICE score = (8 × 6 × 6) ÷ 3 = 96

A two-arm A/B test randomly assigned eligible new users to the existing catalogue or the goal-selector experience. Assignment was at user level, and users remained in the same condition across devices. The team pre-specified a fourteen-day recruitment and seven-day outcome window. It did not stop early when an interim dashboard showed a promising result.

After the test, the control group recorded 1,800 users and 324 first-lesson completions, giving 18.0%. The treatment group recorded 1,790 users and 376 completions, giving approximately 21.0%. The absolute difference was approximately 3.0 percentage points and relative uplift approximately 16.7%.

The team checked exposure logs and found that 4% of treatment users failed to load the selector because of a mobile error. An intention-to-treat analysis retained users in their assigned groups, preserving the benefit of randomisation. A technical follow-up separately examined the exposure failure. Cancellation did not increase, but the confidence interval around that guardrail was wide.

Outcome and decision

The team released the selector to 25% of traffic, fixed the mobile defect, and continued monitoring completion, cancellation, support contacts and course consumption. It did not claim that the selector caused all improvements in learning outcomes; it claimed only that assignment to the selector increased the measured seven-day completion under the tested conditions.

Learning points

  1. A clear mechanism made the intervention testable.
  2. The primary metric and guardrail prevented narrow optimisation.
  3. Exposure validation identified an implementation problem that aggregate results could hide.
  4. A positive result justified staged scaling, not immediate universal rollout.
  5. The learning record included both the causal claim and its limits.

Challenges and Limitations

Experimentation can become counterproductive when teams test trivial interface changes while avoiding difficult strategic questions. Small firms may lack sufficient traffic for conventional A/B tests, and long purchase cycles delay outcomes. Network effects, marketplace liquidity and operational constraints can make individual-level randomisation inappropriate. External events, seasonality and competitor actions may contaminate results.

Statistical methods cannot compensate for a badly defined metric, biased sample or unimportant question. Nor can an experiment determine whether a business model is ethically acceptable. Finally, a culture obsessed with measurable short-term conversion may neglect brand, trust, employee welfare, resilience and long-term customer value.

Best-Practice Checklist

  • Begin with a decision, not a fashionable tactic.
  • State the mechanism and minimum meaningful effect.
  • Define the denominator and eligibility rules precisely.
  • Use ICE or RICE transparently, not mechanically.
  • Pre-specify primary outcomes, guardrails and stopping rules.
  • Randomise where feasible and select the correct unit.
  • Validate assignment, exposure and event instrumentation.
  • Report effect size and uncertainty, not only significance.
  • Separate causal conclusions from descriptive observations.
  • Record negative and inconclusive results.
  • Check heterogeneous effects and ethical consequences.
  • Scale gradually and monitor durability and unit economics.

Chapter Summary

Experimentation is a management system for learning under uncertainty. It begins with falsifiable hypotheses that define a population, intervention, mechanism, outcome and expected magnitude. ICE and RICE help allocate resources, but their scores are subjective indices rather than forecasts. MVPs reduce construction while preserving the assumption being tested.

A/B testing uses random assignment and a control condition to estimate causal effects. Conversion differences, relative uplift, standard errors and confidence intervals provide a quantitative basis for interpretation, provided assumptions about independence, measurement and sample size are reasonable. Statistical significance must be distinguished from practical significance. Power, pre-specified analysis and disciplined stopping reduce false discoveries.

Causal inference requires attention to counterfactuals, confounding, selection, attrition, spillovers and instrumentation. Quasi-experimental methods can be useful when randomisation is impossible, but their assumptions must be defended. Evidence-based organisations counter confirmation bias, p-hacking, survivorship bias and metric gaming through experiment registries, transparent documentation and governance.

Scaling requires more than a positive test: durability, generalisability, profitability, operational capacity, fairness and customer welfare must be considered. Ethical experimentation protects privacy, autonomy and vulnerable groups. Ultimately, the value of experimentation lies not in producing a stream of isolated wins, but in building cumulative organisational knowledge that improves entrepreneurial decisions.

Key Terms

A/B test: A randomised comparison between a control and treatment experience.

Absolute effect: The arithmetic difference between treatment and control outcomes.

Causal inference: Reasoning about whether an intervention produced an outcome.

Confidence interval: An interval procedure expressing uncertainty around an estimated parameter.

Confounding: A variable-related distortion that makes an association differ from the causal effect.

Control group: Units receiving the baseline or comparison condition.

Counterfactual: The outcome that would have occurred under an alternative condition.

Experiment registry: A structured record of experiment questions, methods, results and decisions.

Guardrail metric: A measure used to detect harmful or unacceptable side effects.

Hypothesis: A falsifiable statement predicting an effect under specified conditions.

ICE: A prioritisation index based on impact, confidence and ease.

MDE: Minimum detectable effect considered meaningful for an experiment.

MVP: The smallest credible product or intervention that tests a meaningful assumption.

Power: The probability of detecting a specified effect under stated assumptions.

Primary metric: The principal outcome used to evaluate an experiment.

Randomisation: Assignment by chance to reduce systematic group differences.

RICE: A prioritisation index based on reach, impact, confidence and effort.

Relative uplift: The treatment-control difference expressed relative to the control outcome.

Statistical significance: Evidence against a specified null model at a chosen decision threshold.

Survivorship bias: Distortion caused by analysing only units that remain visible or successful.

Review Questions

Short Answer Questions

  1. What characteristics make a growth hypothesis testable?
  2. Distinguish a primary metric from a guardrail metric.
  3. What are the three components of ICE scoring?
  4. Why is randomisation important in an A/B test?
  5. Why should a positive experiment result not automatically lead to full-scale rollout?

Long Answer Questions

  1. Explain how an entrepreneurial firm can design and govern a complete experimentation system.
  2. Compare ICE and RICE, including their assumptions, strengths and limitations.
  3. Explain the difference between statistical significance and practical significance using a growth example.
  4. Discuss major threats to causal inference in product and marketing experiments.
  5. Explain how documentation and experiment registries contribute to organisational learning.

Analytical / Application Questions

  1. A treatment increases conversion from 8% to 9.2%. Explain how you would report the absolute difference, relative uplift, uncertainty and business relevance before recommending rollout.
  2. A referral experiment randomises individual users, but treated users invite friends who enter the control group. Identify the causal problem and propose a more appropriate design.
  3. A team tests twelve variants and reports the one with p < 0.05, although no primary metric was specified. Diagnose the analytical risks and design a more credible follow-up study.

Multiple Choice Questions with Answers

Question 1

Which statement is the best example of a testable growth hypothesis?

A. Users will enjoy the redesigned homepage.

B. The homepage should look more modern.

C. Adding a progress indicator will increase course completion among new users by at least 5% within 30 days.

D. The design team believes the new page is better.

Correct Answer: C. Adding a progress indicator will increase course completion among new users by at least 5% within 30 days.

Question 2

What is the ICE score when Impact = 8, Confidence = 6 and Ease = 7, using the arithmetic-average formula?

A. 21

B. 112

C. 336

D. 48

Correct Answer: B. 112

Question 3

In an A/B test, randomisation primarily helps to:

A. Guarantee a positive treatment effect

B. Eliminate the need for a control group

C. Balance potential confounding characteristics between groups in expectation

D. Ensure that every user receives both versions

Correct Answer: C. Balance potential confounding characteristics between groups in expectation

Question 4

Control conversion is 10% and treatment conversion is 12%. What is the relative uplift?

A. 2%

B. 12%

C. 20%

D. 120%

Correct Answer: C. 20%

Question 5

Which statement about a p-value is correct?

A. It is the probability that the research hypothesis is true.

B. It is the probability that the observed result was caused by the treatment.

C. It measures the commercial value of the intervention.

D. It quantifies how unusual the data are under a specified null model.

Correct Answer: D. It quantifies how unusual the data are under a specified null model.

Question 6

Which metric is most appropriately described as a guardrail metric?

A. The primary conversion outcome

B. Customer cancellation rate monitored for harmful side effects

C. The number of experiment ideas in a backlog

D. The team’s ICE score

Correct Answer: B. Customer cancellation rate monitored for harmful side effects

Question 7

Which condition is central to a difference-in-differences design?

A. All users must receive treatment.

B. The treatment group must be larger than the comparison group.

C. Treated and comparison groups would have followed parallel trends without treatment.

D. The outcome must be binary.

Correct Answer: C. Treated and comparison groups would have followed parallel trends without treatment.

Question 8

Which practice most directly reduces p-hacking?

A. Stopping whenever a dashboard appears favourable

B. Testing many outcomes and reporting only the best one

C. Pre-specifying the primary metric and analysis plan

D. Removing all negative results from the experiment registry

Correct Answer: C. Pre-specifying the primary metric and analysis plan

Question 9

Why can a high RICE score be misleading if used mechanically?

A. RICE cannot include reach.

B. Its inputs are estimates and may encode unjustified optimism or subjective assumptions.

C. RICE is a statistical significance test.

D. RICE always prioritises low-reach experiments.

Correct Answer: B. Its inputs are estimates and may encode unjustified optimism or subjective assumptions.

Question 10

A treatment produces a statistically significant 0.05 percentage-point increase but adds substantial operational cost. What should the team do?

A. Adopt it automatically because significance proves business value.

B. Reject it automatically because every small effect is meaningless.

C. Compare the effect with costs, risks and strategic value before deciding.

D. Change the primary metric until the effect is larger.

Correct Answer: C. Compare the effect with costs, risks and strategic value before deciding.

Growth Hacking Strategies & Scaling
Chapter 6 of 15